VaramirStart free · no cardSign in
MNKD as of Oct 31 · 20:23 ET
MNKDNasdaqPharmaceutical Preparations

Mannkind Corp · Brief

Next report

3 days

Nov 4 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±9.7%
avg realized
±5.8%
Nov 7 '24±4.3%▼−0.61%×0.14
Feb 26 '25±8.5%▼−4.39%×0.52
May 8 '25±17.0%▼−4.54%×0.27
Aug 6 '25±6.9%▼−13.16%×1.89
Q3 FY25±13.1%▲+10.58%×0.81
Q1 FY26±11.5%▼−7.43%×0.65
May 6 '26±7.3%▼−0.28%×0.04
Q2 FY26±9.4%▼−5.12%×0.54
quarterimplied−20%0+20%realized×
Q2 FY26±9.4%▼−5.12%×0.54
May '26±7.3%▼−0.28%×0.04
Q1 FY26±11.5%▼−7.43%×0.65
Q3 FY25±13.1%▲+10.58%×0.81
Aug '25±6.9%▼−13.16%×1.89
May '25±17.0%▼−4.54%×0.27
2 older reports
Feb '25±8.5%▼−4.39%×0.52
Nov '24±4.3%▼−0.61%×0.14
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 4

5disclosed supplier and customer ties in SEC filingsSEC filings
4tracked funds holding MNKDN-PORT · Aug 31 '26

Bear2 of 4

8 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
20managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

MNKD report session

Customers 1

UTHRUnited Therapeutics×0.21
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±26.1% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.